Optimize Financial’s Globus Medical GMED Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$438K Sell
5,085
-2,025
-28% -$182K 0.22% 159
2025
Q4
$621K Buy
7,110
+100
+1% +$7.59K 0.31% 81
2025
Q3
$401K Buy
+7,010
New +$404K 0.21% 212

Other funds holding GMED

Optimize Financial's GMED Position: Q1 2026 in Review

Optimize Financial reduced its Globus Medical (GMED) stake by 28% in Q1 2026, selling an estimated $182K and leaving 5,085 shares worth $438K. The position accounts for 0.22% of the portfolio, ranked #159.

Optimize Financial first reported a position in GMED in Q3 2025 and has held it in 3 quarters since. The position peaked at $621K in Q4 2025. 602 funds tracked by Wall St. Rank hold GMED as of Q1 2026.

  • Optimize Financial held 5,085 shares of Globus Medical worth $438K as of Q1 2026.
  • Optimize Financial sold 2,025 Globus Medical shares in Q1 2026, an estimated $182K.
  • Globus Medical made up 0.22% of Optimize Financial's portfolio in Q1 2026, its #159 holding.
  • Optimize Financial first reported a position in Globus Medical in Q3 2025 and has held it in 3 quarters since.
  • Optimize Financial's Globus Medical position peaked at $621K in Q4 2025.
  • 602 funds tracked by Wall St. Rank held Globus Medical as of Q1 2026.

Based on Optimize Financial's 13F filing for Q1 2026, filed 12 May 2026.